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ABSTRACT
Supercharged Models of Intrinsically Disordered Proteins and Their Utility in Sensing
by
Peter J. Schnatz

Advisor: Ronald L. Koder

In this thesis I show that greatly increasing the magnitude of a protein’s net charge using surface
supercharging transforms that protein into a ligand-gated or counterion-gated conformational
molecular switch. To demonstrate this I first modified the designed helical bundle hemoprotein
H4 using simple molecular modeling, creating a highly charged protein which both unfolds
reversibly at low ionic strength and undergoes the ligand-induced folding transition commonly
observed in signal transduction by intrinsically disordered proteins in biology. Due to the high
surface charge density, ligand binding to this protein is allosterically activated by low
concentrations of divalent cations and the polyamine spermine. To demonstrate this process
further using a natural protein, I similarly modified E. coli cytochrome b562 and the resulting
protein behaves in a like manner. These simple model systems allow us to derive and then
experimentally validate a mass-action model for coupled folding and binding behavior of ligandgated conformational switches, establishing a set of general engineering principles which can be
used to convert natural and designed proteins into allosteric molecular switches useful in
biodesign, synthetic biology, and sensing.
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Chapter 1: Introduction

In the last ten years, the structural biology and biophysics communities have focused
much effort on the role of intrinsically disordered proteins (IDPs) in biology. These proteins and
protein domains undergo a phase transition between a disordered state and a folded state as part
of their function 1–5. IDPs are found in almost every functional signal transduction pathway in
biology, including cell cycling 6–8, circadian rhythms 9,10, posttranscriptional regulation 11–13, and
protein degradation 14,15. While the majority of IDPs make this phase change in response to
kinase or phosphatase action 16–18, a subclass of these proteins are unstructured until they bind to
another protein or small molecule ligand – a process termed ligand-induced folding 19–21. In
some systems a layer of complexity has been added in which a protein’s interaction with another
molecule will optimize, accelerate, or hinder a process once it has been activated; this process is
known as allostery 22–25. An IDP exhibiting allosteric characteristics is not merely an on/off
switch for its dedicated function, but now possesses the ability to control the velocity at which
some function occurs and with what efficacy. The universality of IDPs in the proteome points to
the utility of phase change in regulation: as form equals function in much of molecular biology,
having the ability to turn form itself, and thus function, on and off is a simple and attractive
method to control individual nodes in complex interaction networks. Therefore, the ability to
design allosteric IDPs, both by modifying natural proteins and by fully de novo IDP design, is
critical to the success of future complex network creation efforts in synthetic biology.
The hallmarks of IDP structure are a high net charge per residue 26–29, a relatively low
core protein folding energy 30,31, and low sequence complexity 32–34. Since charged acidic and
basic residues are common on the solvent accessible surface of the folded protein, their mutation
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often does not significantly change the fold of the final structure, yet it does effect the stability
due to electrostatic interactions 35–38. The tolerance of the protein fold to these changes makes the
net charge per residue the ideal IDP characteristic to use for modulating stability of a natively
structured protein. Commonly, the net charge is a result of a very high charge ratio – for
example, if the protein is negatively charged, there will be very few if any positively charged
side chains 39. This partially destabilizes the folded state of the protein by charge-charge
repulsion 40 and the additional folding energy that results from ligand binding is sufficient to
drive the phase transition from an extended unliganded state to a folded bound state.
The goal of this dissertation is to create natural and artificial IDPs that undergo a
significant phase transition from a predominantly rigid coil to an ordered, folded structure upon
ligand-binding using emergent computational techniques 41–43. I impart this behavior by
incorporating high net charge - mutating the solvent exposed side chains of low net charge
proteins to basic residues. The electrostatic repulsion of the negative charges destabilizes the
structure and forces it to take on characteristics similar to a random coil conformation. By
increasing the solution ionic strength it is possible to screen the side chain charges and reduce the
repulsive forces, switching the energetically favorable conformation from random coil to
natively folded. Similarly, the addition of a ligand will induce folding at the correct ionic
strengths, exhibiting the desired IDP behavior.
Chapter 2 of this dissertation describes the development of design principles used to
impart IDP behavior to a natively folded de novo diheme binding tetrahelical bundle. I will
demonstrate the use of surface residue supercharging to design a protein with a tunable dynamic
range and phase behavior. I will also show that the modification of a protein’s surface to greatly
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increase the magnitude of its net charge imparts the ligand-induced folding behavior found in
natural IDPs.
Chapter 3 describes how the principles developed in Chapter 2 can be used to impart IDP
behavior to a natural natively folded protein, namely E. coli cytochrome b562. An iterative
procedure will be outlined that describes controlled modulation of the stability of a supercharged
protein by rationally selecting point mutations. Further, it will be shown that a supercharged
extant protein can maintain its functional ability even when partially folded.
Chapter 4 of this dissertation demonstrates that clusters of negative charge on a designed
IDP surface imparts a high structural sensitivity to polyvalent cations, driving it to fold at ionic
strengths over three orders of magnitude lower than for monovalent cations. Additionally, I show
that the high density of acidic surface residues imparts cooperative ligand binding behavior in
response to divalent cation and polyamino compound effector molecules – specific ion
interactions that are not commonly observed in high net charge natural IDPs.
Finally, Chapter 5 will describe future applications of this work, specifically pertaining to
the field of biosensing. By using label-free surface plasmon resonance (SPR) spectroscopy, the
interaction between an immobilized protein on a gold nanoparticle with its target ligand can be
evaluated by sensing changes in the refractive index of the immediate vicinity surrounding that
nanoparticle. I will describe how IDPs can be used to increase the sensitivity of SPR biosensing
assays by utilizing the ligand-induced folding properties, which will have an enhanced effect on
the refractive index change surrounding the gold nanoparticles. I will also present preliminary
results showing the potential for the magnitude of this effect compared to the usual assay which
uses proteins that are natively folded.
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This work thus presents a roadmap for the refashioning of natural and designed globular
proteins into cooperative IDPs which may prove useful in the design of new control mechanisms
in natural and designed metabolic networks and in the development of improved biosensors, as
well as creating a new class of maquettes for the study of natural IDP function.
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Chapter 2: Imparting Intrinsic Disorder to a de novo Protein

2.1 Sequence Specific Characteristics of IDPs
Since their discovery less than 30 years ago, the library of proteins empirically known to
be fully or partially unstructured has grown rapidly. The Disordered Protein Database, DisProt 44,
currently contains over 800 entries with experimental evidence for disorder collected from
literature. And the Protein Order and Disorder Database, PODD 45, which contains statistical
ensembles of conformationally heterogeneous states, has over 5000 entries. Furthermore, full
proteome studies using computational disorder predictors 46–48 have shown the disorder content
of eukaryotic and bacteria proteomes average 20.5% and 8.5%, respectively 49. The human
proteome contains an abundance of IDPs with over 30% disorder 50.
The incontrovertible ubiquity of IDPs has led to investigations into the amino acid
composition of proteins and protein domains that are natively unstructured. Early studies of the
amino acid composition have shown that a large net charge and weak hydrophobic character can
impart structural instability leading to a natively unstructured protein 27,28,51,52. The interplay
between these sequence specific characteristics will determine if a structure is natively unfolded.
Using a normalized version of the Kyte and Doolittle approximation of amino acid
hydrophobicity 53, the mean hydrophobicity per residue, 〈𝐻〉, can be calculated. Accordingly, for
a protein domain to be intrinsically disordered, 〈𝐻〉 and the absolute mean net charge per residue
〈𝑅〉 must satisfy the following constraint 29:
〈𝑅〉 > 2.785〈𝐻〉 − 1.151.

(1)

However, net charge per residue is an inadequate predictor for identifying IDPs because a
protein may still be unstructured if the total fraction of charged residues is high and the number
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of oppositely charged residues is relatively the same. Also, if the linear distribution of charged
residues within a near-neutral protein shows clustering of like-charges within domains and
regions, then IDP behavior can be still expected 39. Pappu and coworkers have compiled
experimental data29,54–57 on IDPs to develop a map predicting the phase structure, i.e. randomcoil, molten globule, or native, based on the fraction of charged residues 39,40.
I have implemented these sequence specific constraints throughout this work in designing
functional IDPs and imparting IDP behavior to natively folded designed and extant proteins.

2.2 Materials and Methods
2.2.1 Cloning, Expression, and Purification. The N4(-28) gene was synthesized
(GeneWiz) with an N-terminal TEV protease cut site and inserted between the BglII and XhoI
restriction sites of the pET32a(+) vector plasmid (Novagen). Plasmid DNA was chemically
transformed into BL21(DE3) E. coli cells for expression. The protein was expressed as a fusion
with thioredoxin and purified via hexa-histidine-tag (his-tag) purification procedures: a 2 L
culture of BL21(DE3) E. coli containing the plasmid carrying the N4(-28) gene was grown at 37°
C and induced to express with the addition of 1 mM isopropyl-ß-D-thiogalactoside when OD600
reached approximately 1.2. The culture was shaken overnight for up to 16 h at 18° C or for 2.5 h
at 37° C. Cells were harvested by centrifugation then lysed via high-pressure cell disruption
using a French press. Lysate cell debris was separated by centrifugation and the target fusion
protein was purified via a Ni-nitrilotriacetic acid (Ni-NTA) chromatography (Qiagen) according
to the manufacturer’s instructions. The collected fusion protein was dialyzed into 4 L of 50 mM
Tris-HCl, 1 M NaCl, pH 8.0. The reducing agent, dithiothreitol (DTT), was added to a final
concentration of 1 mM and tobacco etch virus protease was added to cleave N4(-28) from the
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his-tag and thioredoxin overnight at room temperature. The N4(-28) was purified from the histagged thioredoxin via another round of Ni-NTA chromatography and then dialyzed into 6L of
20 mM ammonium carbonate, 2 mM dextrose, pH 7.5 and lyophilized. Finally, resuspended
protein was purified with a C18 reverse-phase column (Western Analytical) using high
performance liquid chromatography (Shimadzu) and lyophilized to a pure product. Protein
identity was confirmed by mass spectrometry with a Bruker Autoflex Speed TOF-TOF.
15

N-Labeled Protein — 15N isotopically labeled protein were grown in M9 minimal media

containing 15NH4Cl as the only nitrogen source 58. All subsequent growth and purification
procedures are the same as for unlabeled protein.
2.2.2 Salt Refolding. CD spectra were recorded on an Aviv Biomedical Circular
Dichroism Spectrometer Model 400 in a quartz cell with a 0.2 cm light path, using a bandwidth
of 1 – 2 nm, an averaging time of 2 s, and averaged over two scans.
For salt refolding experiments, concentrated apo-N4(-28) stocks were prepared at 30 μM
in 20 mM boric acid, 50 mM NaCl, pH 9.0. The stocks were diluted to 2.5 μM in a range of salt
concentration from 50 mM to 2000 mM NaCl. Spectra were recorded between 204 nm and 250
nm, with background correction. The spectra were observed as ellipticity ( [𝜃]𝑜𝑏𝑠 mdeg), and the
mean residue ellipticity ([𝜃], mdeg2 cm dmol-1 residue-1) was calculated as
[𝜃] = [𝜃]𝑜𝑏𝑠 /(10𝑙𝑐𝑁),

(2)

where 𝑙 is the light path length in centimeters, 𝑐 is the sample concentration in millimoles per
liter, and 𝑁 is the number of amino acids in one macromolecule. Protein secondary structure
percentages were calculated with K2D3 59 using data points ranging from 204 nm to 240 nm.
To determine the folding energy of the apoprotein at varying ionic strength the ellipticity
at 222 nm, [𝜃]222 , was plotted as a function of NaCl concentration. The lowest value of [𝜃]222
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reached for the salt titration was considered the point at which the helical bundle is 100% folded
and assigned [𝜃]222,folded . The 0% folded baseline ([𝜃]222,unfolded ) is calculated by using K2D3
59

to determine the predicted alpha-helix percentage (𝑓) at its fully-unfolded state and

normalizing it relative to [𝜃]222,folded :
[𝜃]222,unfolded =

[𝜃]222 −𝑓[𝜃] 222,folded
1−𝑓

.

(3)

The ensemble fraction of protein folded at each salt concentration can be calculated from
the data using Equation 3. Finally, the folding energy as a function of ionic strength, 𝛥𝐺, can be
calculated as
𝑓

𝛥𝐺 = 𝑅𝑇ln(𝐾𝑒𝑞 ) = 𝑅𝑇ln (1−𝑓 ),

(4)

where 𝑅 is the universal gas constant, 𝑇 is the absolute temperature, and 𝐾𝑒𝑞 is the equilibrium
constant between folded and unfolded states.
2.2.3 Chemical Denaturation. Apo-N4(-28) stocks were prepared at 30 μM in 20 mM
boric acid, pH 9.0 and at four salt concentrations (750, 1000, 1500, 2000 mM NaCl). The stocks
were diluted to 2.5 μM in a range of urea concentrations from 0 to 8 M. CD spectra showed no
significant change when the samples were equilibrated for 24 h, therefore equilibration time was
not strictly monitored and was normally on the order of minutes. Spectra were recorded between
210 nm and 250 nm, with background correction. The observed ellipticity spectra were
converted to mean residue ellipticity using Equation 2 and protein secondary structure was
calculated with K2D3 59 using data points ranging from 210 nm to 240 nm. To determine the
folding energy at each salt concentration, the urea melt curves were fit with least squares
regression analysis using the equation 60 :
[𝜃]𝑜𝑏𝑠 =

[𝜃]𝑁 +[𝜃]𝑈 𝑒 −(𝛥𝐺0 −𝑚[𝐷])/𝑅𝑇
1+𝑒 −(𝛥𝐺0 −𝑚[𝐷])/𝑅𝑇
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.

(5)

Here, 𝛥𝐺0 is the folding energy, 𝑚 is an empirical constant determining how the stability
changes with denaturant concentration and is related to the change in accessible surface area of
the protein as it transitions from folded to denatured 61,62, [𝐷] is the denaturant concentration, 𝑅
is the universal gas constant, and 𝑇 is the temperature. Also, [𝜃]𝑁 = 𝜉𝑁 [𝐷] + 𝜉0,𝑁 and [𝜃]𝑈 =
𝜉𝑈 [𝐷] + 𝜉0,𝑈 determine how the signal of the native and unfolded states change with denaturant
concentration, where 𝜉0,𝑖 are the y-intercepts of the native and denatured baselines and 𝜉𝑖 are the
slopes of the baselines.
2.2.4 Cofactor Binding. UV-Vis Spectroscopy — Optical spectra were recorded with a
Hewlett-Packard 8452A diode array spectrophotometer. Apoprotein samples were 0.5 μM in 20
mM boric acid, pH 9.0 with varying NaCl concentrations specifically noted throughout.
Experiments were performed in 1 cm path length glass cuvettes. The cofactor, Fe(III)
Isohematoporphyrin IX (IHP) (Frontier Scientific), was suspended in DMSO at concentrations
between 1 mg/mL and 10 mg/mL. Successive 0.3 – 5 equivalent additions of IHP were followed
by at least a 1.5 min equilibration period. Optical spectra were collected after each equilibration
period and the cofactor binding was monitored using the bound IHP Soret peak at 404 nm.
Values for 𝐾𝑑 were obtained from plots of the Soret band absorbance (𝐴404 ) measured at 404 nm
vs. the concentration of IHP added and fit with least squares regression analysis using the tight
binding equation:

𝐴 = 𝐴0 + 𝜖𝑢𝑛𝑏 [IHP]
+ 𝜖𝑏𝑛𝑑 [prot] [

K d + [IHP] + [prot] − √(𝐾𝑑 + [IHP] + [prot])2 − 4[IHP][prot]
]
2[prot]
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(6)

where 𝐴0 is the initial absorbance at 404 nm, 𝜖𝑢𝑛𝑏 is the molar absorption coefficient of unbound
IHP at 404 nm, 𝜖𝑢𝑛𝑏 is the additional absorbance of bound IHP at 404 nm, [IHP] is the IHP
concentration, [prot] is the protein concentration, and K d is the dissociation constant for oxidized
IHP at a specified salt concentration.
Circular Dichroism Spectroscopy — At low NaCl concentrations, cofactor binding was
monitored via CD spectrometry. Apoprotein samples were 2.5 μM in 20mM boric acid, pH 9.0
and the specified NaCl concentration. Experiments were performed in a 0.2 cm path length
quartz cuvette. IHP was prepared in 100 mM NaOH at 10 mg/mL. Successive 0.25 – 50
equivalent additions of IHP were followed by a 5 min equilibration period. CD spectra were
collected after each equilibration period and the cofactor binding was monitored by the ellipticity
at 222 nm, [𝜃]222 . Values for K d were determined from plots of the [𝜃]222 vs. the concentration
of IHP least squares fit to Equation 6.
2.2.5 Nuclear Magnetic Resonance Spectroscopy. 1H-1H-NOESY — Apoprotein was
concentrated using Centricon YM-3 centrifugal filter concentrators (Millipore). The sample was
directly exchanged into D2O buffer, 20 mM borate, pH 9.0 with the desired NaCl concentration,
using a PD-10 desalting column (GE Healthcare). Three equivalents of heme were added to the
holo-sample prior to buffer exchange. D2O was added to all samples to 10% v/v. Samples were
transferred to 3 mm NMR tubes and nuclear Overhauser effect spectra (NOESY) were taken
using a Bruker AVANCE III HD 700 MHz NMR spectrometer.
1

H- 15N-HSQC — 15N-labeled N4(-28) samples were prepared in the same method as for

NOESY NMR. Samples were exchanged into 90%H2O/10%D2O v/v buffered with 20 mM
NaH2PO4, pH 7.0 at the desired salt concentrations. Lower pH was used to reduce proton
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exchange. 1H-15N heteronuclear multiple quantum correlation (HSQC) spectra were taken using
a Bruker AVANCE III HD 700 MHz NMR spectrometer.
2.2.6 ANS Assay. Monitoring folding — A 10 µM sample of apoprotein was prepared at
20 mM MOPS, 15 mM NaCl, pH 7.0 with a 50-fold excess of ANS. The sample was titrated
with CaCl2 up to 150 mM and the emission spectrum of ANS was monitored via fluorescence
spectroscopy. The excitation wavelength was 370 nm and the emission spectrum was collected
between 400 and 600 nm.
Monitoring heme binding — A 10 µM sample of apoprotein was prepared at 20 mM
MOPS, 15 mM NaCl, 150 mM CaCl2. The sample was titrated with heme up to 33 µM and the
emission spectrum of ANS was monitored via fluorescence spectroscopy. The excitation
wavelength was 370 nm and the emission spectrum was collected between 400 and 600 nm.

11

2.3 Redesigning H4 with IDP Sequence Constraints
The starting point is the designed single-chain diheme tetrahelical bundle protein H4(16), which is a single-chain variant of the homodimeric protein HP-7 41,63. Apo-H4 has a surplus
of negatively charged residues – 16 more acidic than basic residues (Figure 1A). Because of this,

Figure 1: Alphas-carbon representation of H4(-16) (A) and N4(-28) (B). The corresponding amino acid sequence is shown below
each structure with alpha-helix forming regions underlined. The solvent exposed acidic and basic residues are colored red and
blue, respectively. The heme porphyrins are shown in their binding sites as orange stick models.

the apoprotein partially unfolds at low ionic strength as evidenced by a distinctive band at 222
nm when measured by circular dichroism spectroscopy (Figure 2). At low ionic strength, 50 mM
NaCl, H4(-16) is 35% helical as estimated using the circular dichroism protein secondary
structure predictor website K2D3 59. I set out to amplify the property of unfolding at low ionic
strength by increasing the net charge. The software package ProtCAD 64 was used to create a
structural model for holo-H4, and every fully surface-exposed side chain was charged to
glutamic acid, creating an H4 variant termed N4(-52) with 52 excess negatively charged side
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chains. H4 also contains low helical-propensity aspartate and asparagine side chains 65 that were
added to increase chemical shift dispersion 63, and these were reverted to their high-propensity
analogues glutamate and glutamine. This protein did not fully fold even at high salt
concentrations. 52 acidic residues comprise 40% of the residues, a net charge per residue higher
than the 35% cut-off value identified by Pappu and coworkers as the random coil limit 39. I then
created the protein N4(-28) by changing every lysine residue in H4 to glutamine and handselecting a subset of surface-exposed residues to become acidic such that 21% of the protein side
chains are negatively charged, there are no basic residues except for the four heme ligand
histidines, and the charged surface side chains are maximally distant from each other. This net
charge per residue lies in the region predicted by Pappu and coworkers to exhibit ligand-induced
folding behavior.

Figure 2: A. Ellipticity spectra of H4(-16) as measured by circular dichroism spectroscopy at increasing NaCl concentrations. B.
The ellipticity value at 222 nm, corresponding to the absorption band indicative of alpha-helical structure plotted as a function of
NaCl concentration. Protein was prepared at a concentration of 2.5 µM in 20 mM borate, pH 9.0 with varying NaCl
concentrations.

13

2.4 Salt Dependence of the Folding Energy
In pH 9.0, 20 mM borate buffer, apo-N4(-28) has a circular dichroism (CD) spectrum
indicative of a predominantly random coil structure at NaCl concentrations less than 200mM
(Figure 3A). Helices form as the salt concentration is increased, and the CD spectra show the 222
nm band characteristic of alpha-helices (Figure 3A). The protein becomes predominantly helical
at concentrations over 1 M NaCl (Figure 3B). Figure 4 illustrates the salt-induced folding
transition of N4(-28) as detected by circular dichroism: at low salt concentrations the protein
takes on a random coil conformation, which folds to the native-like tetrahelical bundle as the
ionic strength increases.

Figure 3: A. Ellipticity spectra of apo-N4(-16) as measured by circular dichroism spectroscopy at increasing NaCl
concentrations. B. The ellipticity value at 222 nm, corresponding to the absorption band indicative of alpha-helical structure
plotted as a function of NaCl concentration. Protein was prepared at a concentration of 2.5 µM in 20 mM borate, pH 9.0 and
varying NaCl concentrations.
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Figure 4: A schematic illustration of the N4(-28) phase transition from an extended random coil to a folded tetrahelical bundle
upon the addition of NaCl.

Figure 5 depicts urea denaturation experiments conducted at higher salt concentrations,
between 750 and 2000 mM. The folding energies, 𝛥𝐺fold , from the fits to Equation 5 are
summarized in Table 1. Similar to the salt plot of Figure 3B, the results show that increased ionic
strength stabilizes the folded state of apo-N4(-28).

Figure 5: Urea melts of N4(-28) at pH 9.0, 20 mM borate with NaCl concentrations ranging from 0.75 to 2 M. The fits were
calculated using the non-linear method of least squares to Equation 5. The melt for each salt concentration was performed three
times and averaged. The error bars show the standard deviation of three trials at each salt concentration.
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[NaCl] (M)
0.75
1.00
1.50
2.00

𝛥𝐺fold (kcal/mol)
-0.7 ± 0.1
-2.4 ± 0.5
-4.7 ± 0.2
-6.5 ± 0.2

Table 1: The folding energy of N4(-28) at salt concentrations ranging from 0.75 to 2 M as determined by urea melt and least
squares fit to Equation 5. Errors are determined using the inverse matrix method.

Together, the salt titration and urea melt data demonstrate that the folding energy of apoN4(-28) depends linearly on salt concentration over a range of 8 kcal/mole (Figure 6). At ionic
strength less than approximately 400 mM NaCl, the electrostatic repulsion of the neighboring
negatively charged glutamate residues cannot be overcome by the hydrophobic effect, thus
driving the ensemble to be in an extended state. At ionic strength greater than 400 mM NaCl, the
electrostatic fields of the charged residues begin to be screened by the ions in solution. This
screening effect reduces the electrostatic energy of the structure, allowing the hydrophobic effect
to be the overwhelming force which drives N4(-28) to fold and exhibit a predominantly helical
structure.
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Figure 6: Stability of apo-N4(-28) at 20 mM borate, pH 9.0 as a function of NaCl concentration as measured by salt titration and
urea melt. The data was fit with a linear best fit line.

Although CD spectra indicate that the ensemble of N4(-28) is more than 90% folded at
salt concentrations greater than 1 M NaCl (Figure 3B), the free energy of folding continues to
decrease at a constant rate well beyond this threshold (Figure 6). This continuous decrease of the
folding energy far into the regime where the entire ensemble is folded indicates that screening
effects influence the stability of the folded structure with equal magnitude as when the structure
energetically favors the unfolded state. The invariable slope of Figure 6 suggests that only the
solvent exposed residues are influenced by ionic strength and the core residues, which are
inherently not well-solvated when N4(-28) is folded, are unaffected by changes in salt
concentration.
1

H-1H-NOESY and 1H-15N-HSQC spectra of the apoprotein at low salt, 50 mM NaCl, are

consistent with an extended conformation 66–68 (Figure 7A and Figure 8A). Due to the high
flexibility of N4(-28) at low ionic strength, the chemical shift contributions are averaged out and
many resonances overlap. At high salt, 1000 mM for NOESY and 750 mM for HSQC,
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apoprotein has NMR spectra consistent with that of a molten globule, the same structural state
that the apoprotein form of H4’s progenitor protein, HP7, forms (Figure 7B and Figure 8B) 63.
The molten globular state will allow some freedom for the helices to move relative to each other,
disallowing full dispersion of resonance peaks due to discrete chemical shifts. This data
demonstrates that Figure 4, illustrating the phase change of N4(-28) with increased ionic strength
would be better represented as transitioning from extended coil to molten globular, not native
(Figure 9).

Figure 7: 1H-1H NOESY NMR of apo-N4(-28) in 20 mM borate, pH 9.0 with 50 mM NaCl (A) and 1000 mM NaCl (B).
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Figure 8: 1H-15N HSQC NMR of apo-N4(-28) in 20 mM NaH2PO4, pH 7.0 with 50 mM NaCl (A) and 750 mM NaCl (B).

Figure 9: A schematic illustration of the N4(-28) phase transition from an extended random coil to a folded tetrahelical bundle
upon the addition of NaCl.

This data demonstrates that the folding energy of apo-N4(-28) depends linearly on salt
concentration as the electrostatic screening increases; however, it does not reach its lowest
energy native conformation by charge screening alone. Importantly, at low salt concentrations
the folding energy is positive, offering the opportunity for folding to be triggered by the coupled
stabilizing energy of cofactor binding.
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2.5 Ligand-Induced Folding
Thermodynamic measurements of heme binding were not successful at high salt
concentrations because ferric and ferrous hemes both form irreversible aggregates on a minutes
time scale (not shown). Instead the heme analogue Fe(III)-isohematoporphyrin IX (IHP) (Figure
10) was used, which was found to be soluble for hours at NaCl concentrations up to 1 M. The
tetrahelical bundle N4(-28) binds two equivalents of IHP in a hexacoordinate manner and is bishistidine-ligated in the oxidized state (Figure 11). At 20 mM borate, 1 M NaCl, pH 9.0, when the
protein is in its molten globular state according to NMR spectroscopy, N4(-28) binds tightly to
two molecules of IHP independently (Figure 11), with a dissociation constant of 0.21 ± 0.02 µM.
As the ionic strength of the solution is lowered, the dissociation constant increases, indicating
that IHP binds less tightly with decreased NaCl concentration. At 300 mM NaCl, the binding
constant is too weak to monitor via the Soret band using UV-Vis spectroscopy. As an alternative,
CD spectroscopy was used and the ellipticity at 222 nm was monitored to determine the binding
constant: 25 ± 5 µM (Figure 12). No cooperativity was detected at any salt concentration.
Table 2 and Figure 13 summarize the dissociation constants, 𝐾𝑑 , and the corresponding
app

apparent binding energies, 𝛥𝐺bind , of N4(-28) in the range 300 mM — 1000 mM NaCl, for
which there is over a 100-fold increase of the dissociation constant of IHP.

Figure 10: Structure of Fe(III)-isohematoporphyrin IX; a bis-His binding porphyrin with higher water solubility than heme.
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Figure 11: A. Absorption spectra of N4(-28) titrated with concentrated IHP in 20 mM borate, 1000 mM NaCl, pH 9.0. B. Replot
of the IHP Soret band at 404 nm during titration. Data is fit to Equation 6.

Figure 12: A. Ellipticity spectra of N4(-28) as measured by circular dichroism spectroscopy at increasing IHP concentrations at
20 mM borate, 300 mM NaCl, pH 9.0. B. Replot of the ellipticity value at 222 nm, corresponding to the absorption band
indicative of alpha-helical structure plotted as a function of IHP concentration. Protein was prepared at a concentration of 2.5 µM
in 20 mM borate, 300 mM NaCl, pH 9.0. Data was fit to Equation 6.
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3
Figure 13: The dissociation constant of N4(-28) binding with two IHP molecules as a function of salt concentration buffered
with 20 mM borate, pH 9.0. The binding constant was determined using the method of least squares fit to Equation 6 and
averaged over 3-4 trials. The error bars are the standard deviation of the data at each salt concentration.

[NaCl] (M)
0.30
0.40
0.50
0.60
0.75
1.00

app

𝐾𝑑 (µM)

𝛥𝐺bind (kcal/mol)
-6.3 ± 0.1
-7.12 ± 0.08
-7.82 ± 0.03
-7.82 ± 0.01
-8.7 ± 0.3
-9.24 ± 0.07

25 ± 5
7±1
2.2 ± 0.1
2.16 ± 0.05
0.5 ± 0.2
0.2 ± 0.02
𝐚𝐩𝐩

Table 2: The dissociation constant, 𝑲𝒅 , and apparent binding energy, 𝜟𝑮𝐛𝐢𝐧𝐝 , of N4(-28) with IHP over a range of salt
concentrations. Dissociation constants are determined using least squares fits of binding curves to Equation 6 and errors are
determined using the inverse matrix method.

Notably, a measurable binding constant is obtained at 300 mM NaCl, a salt concentration
where N4(-28) is predominantly unfolded. Circular dichroism spectra of the protein during the
titration demonstrate helical formation concomitant with heme binding (Figure 12). 1H-1HNOESY analysis of the holoprotein under the same conditions demonstrates the degree of
chemical shift resolution consistent with a natively folded tetrahelical bundle (Figure 14).
Similarly, 1H-15N-HSQC performed at 20 mM NaH2PO4, 100 mM NaCl, pH 7.0, also showed a
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great increase in chemical shift dispersion of the holoprotein vs both the extended and molten
globular apoprotein. The HSQC resolution increase upon binding IHP is especially significant,
since a salt titration at pH 7 indicates that N4(-28) is merely 11% folded. Thus under both of
these solution conditions, i.e. 20 mM borate, 300 mM NaCl, pH 9.0; and 20 mM NaH 2PO4, 100
mM NaCl, pH 7.0, N4(-28) exhibits the ligand-induced folding behavior, going from an
extended random coil structure to a native-like folded structure, seen in natural IDPs.

Figure 14: A. 1H-1H-NOESY NMR of holo-N4(-28) in 20 mM borate, 300 mM NaCl, pH9.0. B. 1H-15N-HSQC NMR of holoN4(-28) in 20 mM NaH2PO4, 100 mM NaCl, pH 7.0.

To corroborate the NMR data, an ANS assay was performed. The fluorescent dye 8anilino-1-naphthalenesulfonic acid (ANS) has been commonly used as probe for clusters of
hydrophobic residues in proteins 69–71. At low ionic strength, when N4(-28) is an extended coil,
the ANS has a characteristic unbound fluorescence peak at 525 nm (Figure 15A). When the ionic
strength is increased, the peak increases in magnitude and blue shifts, indicating that the ANS
has bound to a the hydrophobic environment created in the core of the molten globule N4(-28).
Furthermore, when the heme ligand is introduced, the magnitude of the ANS fluorescence
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decreases and red shifts (Figure 15B). When the heme binds, the protein fold is locked into
place, tightening the core and displacing the ANS.

Figure 15: A. ANS emission spectrum with unfolded apo-N4(-28) at 20 mM MOPS, 15 mM NaCl and bound to molten globule
N4(-28) after the addition of 100 mM CaCl2. B. ANS emission spectrum bound to folded N4(-28) at 20 mM MOPS, 15 mM
NaCl, 100 mM CaCl2, and unbound after the heme is introduced to bind to the protein core.

This data leads to the coupled folding and binding scheme in Figure 16, where N4(-28)
can take the path of transitioning from extended random coil to molten globule with increased
ionic strength, then locking into a native-like folded structure upon binding to IHP. However, the
ligand-induced folding pathway, typical of natural IDPs, is also available at experimentally
determined NaCl concentrations.
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Figure 16: Thermodynamic box of N4(-28) indicating three possible states: extended random coil, molten globule, and nativelike bound. The red arrow demonstrates the pathway of ligand-induced folding typical of many natural IDPs. The energy change
for each leg of the cycle is related to its measurable equilibrium constant.

2.5.1 Coupled Binding and Folding. The apparent binding energy of the ligand under a
particular solution condition is the intrinsic interaction energy between the ligand and the folded
protein (ΔGbind) increased by the energetic cost required to shift the protein population
completely to the folded state 72:
app

ΔGbind = ΔGbind + ΔGfold .

(7)

This ligand-induced folding is illustrated in Figure 16 where ΔGfold and K fold are the apoprotein
folding energy and equilibrium constant, ΔGbind and K d are the binding energy and intrinsic
app

app

dissociation constant of the ligand for the fully folded state, and ΔGbind and K d

are the

binding-folding energy and dissociation constant measured for a two-state equilibrium
population of IDPs. From this thermodynamic cycle it follows that:
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app

Kd

Kd

=K

fold

,

(8)

which demonstrates that the apparent binding energy is a function of the folding energy of the
unbound protein. The intrinsic dissociation constant, K d , is a fixed parameter for the cofactorbinding site pair. In N4(-28), IDP behavior is imparted by the addition of negatively charged
residues to the surface of the folded structure, making ΔGfold a tunable parameter sensitive to the
ionic strength of the environment.
As Equation 8 predicts and Figure 13 demonstrates, increasing salt concentrations
exponentially decreases the apparent dissociation constant up to the 1M salt limit by decreasing
the energetic cost of folding, and the apparent binding energy decreases linearly with Debye
length, which describes the distance that the electrostatic effect of a charge persists in an
electrolyte solution (Figure 17). Interestingly, binding becomes tighter even after the protein is
predominantly folded as detected by circular dichroism.

Figure 17: The apparent binding energy of N4(-28) with IHP at 20 mM borate, pH 9.0 as a function of Debye length.
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When plotted together (Figure 18A), it is obvious that the values of the apparent binding
app

energy, ΔGbind and the folding energy, ΔGfold , as a function of salt concentration are
approximately parallel. From the closed thermodynamic box of Scheme 1, the intrinsic binding
energy is equal to the apparent binding energy when the folding energy is zero, i.e. when there is
an equal population of unfolded and folded states; this occurs at a salt concentration of 400 ± 10
mM. The apparent binding energy at this salt concentration is -7.11 ± 0.08 kcal/mol,
corresponding to an apparent dissociation constant of 7 ± 1 µM. The average distance between
the two lines is -7.1 ± 0.4 kcal/mol, indicating that the model in Figure 16 holds over the range of
salt concentrations that are experimentally accessible, and the interaction energy between IHP
and the folded protein is the separation. When plotted as a function of Debye length, the folding
energy of N4(-28) shows two distinct regions where the energy drops faster at lower Debye
lengths. The change in slope occurs at approximately 3.5 Å, which may be about twice the
closest distance that the carboxyl groups of neighboring glutamate residues can achieve when not
hindered by electrostatic forces. This demonstrates that the most difficult electrostatic force to
overcome, namely that between neighboring glutamate residues, is effectively turned off once
the ionic strength screens them from each other completely.
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Figure 18: The folding energy of N4(-28) and the binding energy of IHP to N4(-28) plotted together as a function of A. NaCl
concentration and B. Debye length at 20 mM borate, pH 9.0.

Thus I have shown that for a supercharged protein, the effective binding constant can be
controlled using the salt concentration with a dynamic range of at least 142.9 ± 0.2 fold,
suggesting that for a given salt concentration the effective binding constant could likewise be
controlled over a similar range by adjusting the surface charge density.
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Chapter 3: Imparting IDP Behavior to a Natural Protein

3.1 Supercharging E. coli cytochrome b562
To demonstrate that the design principles I have developed in Chapter 2 can be used to
impart IDP behavior to other proteins, I have selected the four alpha-helix bundle E. coli
cytochrome b562 for supercharging. This soluble, 106 residue protein non-covalently binds a
single b-type heme. Both the apo- 73 and holoprotein 74 structures have been solved, providing a
unique and well-established landscape for developing an intrinsically disordered version capable
of ligand-induced folding. Wildtype cytochrome b562 has a net charge of -3, and the holoprotein
has been shown to have slightly more helical content than the apoprotein 75. To allow for easy
tracking and concentration determination, an absorptive tryptophan residue has been substituted
into the structure (F61W); this mutation has proven to be tolerable with only small changes to the
apoprotein folding energy and heme binding constant 76. I have denoted the wildtype cytochrome
b562 with the F61W mutation b562(WT) (Figure 19).
A supercharged cytochrome b562, has been designed using a combination of
computational techniques 77 and simple modeling to select solvent-exposed basic and
neutral residues as candidates for mutation to neutral and acidic amino acids. I focused the
mutations on arginine, lysine, asparagine, and glutamine, with few exceptions, and I did not
mutate residues essential for heme binding or in close proximity to the binding site. My initial
design has 19 mutations to generate a net charge of -27, denoting the new protein b562(-27),
constituting a charge per residue of approximately -0.25 (Figure 19). Having 27 more acidic
residues than basic ones placed the net charge at 25% of the total protein, an amount that is
below the 35% cut-off identified by Pappu as the random coil limit 39; however, it is slightly
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higher than the 21% characteristic of N4(-28). Since mutating residues near the heme binding
site was avoided, there remains five positively charged residues in the protein. The combination
of positively and negatively charged residues will have a stabilizing affect on the protein 78,79,
which was the motivation to increase the net charge percentage from 21%, like that of N4(-28),
to 25%. All charged residues are maximally distant from each other in order to distribute charge,
and consequently instability, over the entire structure.

Figure 19: Alphas-carbon representation of b562(WT) (A) and b562(-27) (B). The corresponding amino acid sequence is shown
below each structure with alpha-helix forming regions underlined. The solvent exposed acidic and basic residues are colored red
and blue, respectively. The heme porphyrins are shown in their binding sites as orange stick models.

3.2 Materials and Methods
3.2.1 Cloning, Expression, Purification, and Point Mutations. The proteins, b562(WT)
and b562(-27) genes was synthesized (GeneWiz) with an N-terminal TEV protease cut site and
inserted between the BglII and XhoI restriction sites of the pET32a(+) vector plasmid
(Novagen). Point mutations were made using the Q5® Site-Directed Mutagenesis Kit (New
England BioLabs) according to the manufacturer’s instructions. Expression and purification of
b562(WT), b562(-27), and the subsequent generations with point mutations is described in detail
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in section 2.3.1. Primers for point mutations and full sequences of all b562 variants are in Table
3 and Table 4.
3.2.2 Salt Refolding. CD spectra were recorded on an Aviv Biomedical Circular
Dichroism Spectrometer Model 400 in a quartz cell with a 0.2 cm light path, using a bandwidth
of 1 – 2 nm, an averaging time of 2 s, and averaged over two scans.
For salt refolding experiments, concentrated apoprotein stocks were prepared at 30 μM in
20 mM MES, 15 mM NaCl, pH 5.5 or 20 mM MOPS, 15 mM NaCl, pH 7.0. The stocks were
diluted to 2.5 μM in a range of salt concentration from 0.8 mM to 3940 mM NaCl. Spectra were
recorded between 210 nm and 250 nm, with background correction. Analysis of the spectra and
determination of the folding energy is described in section 2.3.2.
3.2.3 Cofactor Binding. Binding Constant Determination — Optical spectra were
recorded with a Hewlett-Packard 8452A diode array spectrophotometer. Apoprotein samples
were 1 μM in 20 mM MES, pH 5.5 with varying NaCl concentrations specifically noted
throughout. Experiments were performed in 1 cm path length glass cuvettes. The cofactor,
Fe(III) Isohematoporphyrin IX (IHP) (Frontier Scientific), was suspended in DMSO at
concentrations between 1 mg/mL and 10 mg/mL. Successive 0.3 – 5 equivalent additions of IHP
were followed by at least a 5 min equilibration period. Optical spectra were collected after each
equilibration period and the cofactor binding was monitored using the bound IHP Soret peak at
406 nm. Values for K d were obtained from plots of the Soret band absorbance (𝐴406 ) measured
at 406 nm vs. the concentration of IHP added and fit with least squares regression analysis using
Equation 6.
Kinetics — Optical spectra were recorded with a Hewlett-Packard 8452A diode array
spectrophotometer. Apoprotein samples were 5 μM in 20 mM MOPS, pH 7.0 with varying NaCl
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concentrations specifically noted throughout. Experiments were performed in 1 cm path length
glass cuvettes. The cofactor, Fe(III) Isohematoporphyrin IX (IHP) (Frontier Scientific), was
suspended in DMSO at concentrations between 1 mg/mL. One addition of 1 equivalents of IHP
was added and quickly mixed. Spectra were collected every 30.44 s for up to 30 min. Rate
constants for IHP binding were determined by replotting the Soret band absorbance, 𝐴406 ,
against time and fitting to the equation
𝐴406 = 𝐴0 𝑒 −𝑘𝑡 + 𝑏.

(9)

Here, 𝐴0 is the initial absorbance at 406 nm, 𝑘 is the rate constant, 𝑡 is time, and 𝑏 is the offset.
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Table 3: Protein sequences for E. coli cytochrome b562 variants.

Protein
b562(WT)
b562(-27)
b562(-25)
b562(-21)
b562(-19)
b562(-18)

Protein Sequence
GADLEDNMET LNDNLKVIEK
DFRHGFDILV GQIDDALKLA
GADLEDNMET LNDNLQVIEK
DWEEGFDILV EEIDDALELA
GADLEDNMET LNDNLQVIEK
DWEEGFDILV EEIDDALELA
GADLEDNMET LNDNLQVIEK
DWEHGFDILV GEIDDALKLA
GADLEDNMET LNDNLKVIEK
DWEHGFDILV AEIDDALKLA
GADLEDNMET LNDNLKVIEK
DWEHGFDILV AEIDDALKLA

ADNAAQVKDA
NEGKVKEAQA
ADNAAQVEDA
NEGQVEEAQA
ADNAAQVEDA
NEGQVEEAQA
ADNAAQVEDA
NEGQVEEAQA
ADNAAQVEDA
NEGQVEEAQA
ADNAAQVEDA
NEGQVEEAQA

LTKMRAAALD
AAEQLKTTRN
LEQMEAAALD
AAEELKETRN
LTQMEAAALD
AAEELKTTRN
LTQMEAAALD
AAEELKTTRN
LTQMEAAALD
AAEQLKTTRN
LTQMEAAALD
AAEQLKTTRN

AQKATPPKLE
AYHQKYR
AQQATPPKLE
AYHQEYR
AQQATPPKLE
AYHQEYR
AQQATPPKLE
AYHQEYR
AQQATPPKLE
AYHQEYR
AQQATPPKLE
AYHQEYR

DKSPDSPEMK
DQSPDSPEMS
DQSPDSPEMS
DQSPDSPEMS
DQSPDSPEMS
DQSPDSPEMK
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Table 4: Primers for variants of E. coli cytochrome b562.
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Primer Name
b562-F61W_F
b562-F62W_R
SC-b562-E31T_F
SC-b562-E31T_R
SC-b562-E96T_F
SC-b562-E96T_R
SC-b562-E70G_F
SC-b562-E70G_R
SC-b562-E63H_F
SC-b562_E63H_R
SC-b562-E77K_F
SC-b562-E77K_R
SC-b562-Q15K_F
SC-b562-Q15K_R
SC-b562-E93Q_F
SC-b562-E93Q_R
SC-b562-G70A_F
SC-b562-G70A_R
SC-b562-S59K_F
SC-b562-S59K_R

Primer Sequence
TGGCGTCACGGTTTCGACATTCTGGTTG
GTCTTTCATTTCTGGGGAGTCTGGAGATTTGTCC
ACGCAAATGGAGGCTGCCGCACTGG
TAAAGCGTCTTCAACTTGGGCTGCATTATCTGCTTTCTCG
ACCACCCGTAACGCCTACCACCAAG
TTTCAGCTCTTCGGCAGCAGCTTGGGC
GGCGAGATTGATGATGCTTTAGAGCTGGCGAACGAAGG
CACCAGAATGTCGAAGCCTTCCTCC
CATGGCTTCGACATTCTGGTTGGTGAGATTGATGATGC
CTCCCAATCGCTCATTTCAGGGCTATCTGGG
AAGCTGGCGAACGAAGGTCAAG
TAAAGCATCATCAATCTCTCCCACCAGAATGTCGAAGC
AAGGTTATCGAGAAAGCAGATAATGCAGCCCAAG
TAAATTGTCGTTTAAAGTCTCCATGTTATCCTCCAGATCG
CAACTGAAAACCACCCGTAACGCCTACC
TTCGGCAGCAGCTTGGGCTTC
GCGGAGATTGATGATGCTTTGAAGCTGGCGAACGAAGG
CACCAGAATGTCGAAGCCATGCTCCC
AAGGATTGGGAGCATGGCTTCGACATTCTG
CATTTCAGGGCTATCTGGGCTCTGATC

Predecessor Protein
Wildtype cytochrome b562
b562(-27)
b562(-27)
b562(-27)
b562(-27)
b562(-27)
b562(-25)
b562(-25)
b562(-25)
b562(-25)
b562(-25)
b562(-25)
b562(-21)
b562(-21)
b562(-21)
b562(-21)
b562(-21)
b562(-21)
b562(-19)
b562(-19)

3.3 Salt Dependence of the Folding
At 20 mM borate, pH 9.0, apo-b562(-27) has a CD spectrum indicative of predominantly
random coil structure at salt concentrations in the range 0 – 4 M NaCl. Due to the high net
charge of our initial design, the electrostatic repulsive force between the glutamates overwhelms
the core packing energy. In order to reduce this high electrostatic energy, the pH can be lowered
such that a small population of the glutamic acid residues will be protonated at all times, thereby
lowering the net charge of the protein. Consequently, b562(-27) alpha-helix character is not
detectable by CD spectroscopy until the pH is lowered to 5.5 and the NaCl concentration is at
least 2 M (Figure 20). The protein becomes predominantly helical at concentrations over 3 M
NaCl.

Figure 20: A. Ellipticity spectra of apo-b562(-27) as measured by circular dichroism spectroscopy at 20 mM MES, pH 5.5 and
increasing NaCl concentrations. B. The ellipticity value at 222 nm, corresponding to the absorption band indicative of alphahelical structure plotted as a function of NaCl concentration. Protein was prepared at a concentration of 2.5 µM in 20 mM MES,
pH 5.5and varying NaCl concentrations.

The salt titration demonstrates that the folding energy of apo-b562(-27) depends linearly
on salt concentration (Figure 21). At ionic strength less than approximately 2250 mM NaCl, the
electrostatic repulsion of the negatively charged glutamate residues cannot be overcome by the
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core packing-driven hydrophobic effect, thus driving the ensemble to be in an extended state. At
ionic strength greater than 2250 mM NaCl, the electrostatic fields of the charged residues begin
to be screened by the ions in solution. This screening effect reduces the electrostatic energy of
the structure, allowing the hydrophobic effect to be the overwhelming force which drives b562(27) to fold and exhibit a predominantly helical structure.

Figure 21: Stability of apo-b562(-27) at 20 mM MES, pH 5.5 as a function of NaCl concentration as measured by salt titration
and urea melt. The red line is a linear fit.

3.4 Ligand-Induced Folding
The tetrahelical bundle, b562(-27), non-covalently binds one equivalent of IHP ligated to
the residues M7 and H102 80. At 20 mM MES, pH 5.5 and NaCl concentrations higher than 1 M,
IHP forms aggregates within minutes, hence reliable binding titrations cannot be performed in
order to determine the ligand binding constant. However, this aggregation does not preclude
monomeric IHP in solution from binding to the protein. Therefore, it is confirmed that b562(-27)
retains its ability to bind IHP when it is mostly folded, i.e. at high salt (Figure 22), via UV-Vis
spectroscopy an observing the 406 nm Soret band of bound oxidized IHP. Furthermore, ligand-
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induced partial folding has been confirmed. At 20 mM mES, 2 M NaCl, pH 5.5, titrated with
IHP, b562(-27) only exhibits an increase in its alpha-helical character from 31% to 57% (Figure
23), never reaching the full helical content observed with the NaCl titration alone (Figure 21)
even with as much as 1500 equivalents of IHP. Although, due to IHP aggregation at low pH and
high salt, no definitive binding constants can be collected, this data demonstrates that the
supercharged version of E. coli cytochrome b562 exhibits IDP behavior.

Figure 22: Absorption spectra of b562(-27) titrated with concentrated IHP in 20 mM MES, 3000 mM NaCl, pH 5.5. B. Replot of
the IHP Soret band at 404 nm during titration. Data is fit to Equation 6.
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Figure 23: CD absorption spectrum of b562(-27) titrated with IHP at 20 mM MES, 2 M NaCl, pH 5.5.

It has become clear that, while I have succeeded in disrupting the stability of b562(WT),
the magnitude of the disruption has made the supercharged protein prohibitively unstable,
disallowing experiments to be performed under solution conditions that are tolerable for oxidized
IHP binding. To reduce the electrostatic effects of the surface charged residues, the simplest
approach is to select surface-exposed acidic or neutral amino acids and mutate them to neutral or
basic amino acids, respectively.

3.5 Redesign of Supercharged Cytochrome b562
The net charge of the b562(-27) was iteratively reduced by targeting areas where
negatively charged residues were more highly clustered and mutating one or two of the amino
acids back to the amino acid found at that location in b562(WT). The result of this iterative
procedure yielded four more supercharged b562 proteins: b562(-25), b562(-21), b562(-19), and
b562(-18), with net charge per residue of -0.24, -0.20, -0.18, and -0.17, respectively (Table 3).
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The first two attempts at lowering the net charge, b562(-25) and b562(-21), did not have
improved stability over b562(-27) (Figure 24). The two lowest charged variants, b562(-19) and
b562(-18), showed an improved stability of 1.6 and 2.1 kcal/mol, as determined by the intercept
of folding energy at 0 M NaCl (Figure 24). Consequently, b562(-18) can be folded at pH 7.0
(Figure 25), for which IHP and heme do not aggregate as quickly as when at pH 5.5.

Figure 24: Stability of supercharged variants of apo-b562 at 20 mM MES, pH 5.5 as a function of NaCl concentration as
measured by salt titration. The data was fit with a linear best fit line.

Figure 25: A. CD absorption spectra of apo-b562(-18) at 20 mM MOPS, pH 7.0 and NaCl concentrations ranging from 0 to 4 M.
B. The folding energy as a function of salt of b562(-18).
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3.6 Ligand-Induced Folding and Kinetics of Redesigned Supercharged b562
Thermodynamic measurements with IHP were unsuccessful because the binding constant
was too weak to measure due to its partial hydrophilic character. Instead oxidized ferric heme
was used, which was found to bind well to b562(-18) over the target NaCl concentrations.
At 20 mM MOPS, 2 M NaCl, pH 7.0 apo-b562(-18) is predominantly unfolded as
determined by circular dichroism spectroscopy (Figure 26). The protein can be induced to fold
upon the addition of heme, whereby the energy of the bound cofactor within the folded structure
is lower than the extended coil (Figure 26). However, the holoprotein at 2 M NaCl was found to
be only 58% folded when the CD spectrum was compared to that of apoprotein at high ionic
strength, a behavior similar to its progenitor, b562(-27). The data indicates that the protein only
needs to be partially folded to form a stable bond between the heme and its binding site; portions
of the protein distant from the binding site may not be induced to fold and remain extended at
low ionic strength in the holoprotein.
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Figure 26: Apo- and holo-b562(-18) CD spectra of b562(-18) at 20 mM MOPS, 2 M NaCl, pH 7.0.

At all concentrations of NaCl tested, heme binds on the time scale of minutes (Figure
27A). Due to this slow, stochastic process, there is competition between the binding and heme
aggregation; therefore, once binding stops, the Soret band begins to decay. Interestingly, as the
NaCl concentration increases, the effective rate constant decreases (Figure 27B). The nonsupercharged version, b562(WT), shows a similar effect, indicating that the reduction of the on
rate with increasing NaCl concentration is not a result of supercharging (Figure 27). It is
important to note that for b562(-18), the fraction of the protein that is bound increases with
higher salt, whereas for b562(WT) the fraction bound remains the same for all salt
concentrations, as evidenced by the final magnitude of the Soret band absorbance once the
binding is complete.
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Figure 27: A. The Soret band absorbance (𝑨𝟒𝟏𝟔 ) of heme binding with b562(-18) as a function of time over a range of time at
NaCl concentration ranges from 1.0 M to 4.0 M. Data was fit with Equation 9, and the fitted data was truncated prior to the decay
of the Soret band due to heme aggregation. B. The effective rate constant as a function of NaCl concentration for both b562(WT)
and b562(-18)

Due to the slow binding of heme with b562(-18) and its competition with aggregation, it
is not possible to determine the binding energy under these conditions. Another iteration of
mutations, in which the net charge of b562(-18) is lowered, thereby stabilizing the protein further
may allow for faster heme binding or IHP binding at salt concentrations for which the
aggregation is slower.
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Chapter 4: Divalent Cations and Cooperativity

4.1 Background
Metal cations are crucial for many biological pathways and functions. Metalloproteins
and metal-sensitive proteins have been receiving increased interest as their role in protein
stability and catalysis becomes better understood 81–84. For protein folding, divalent cations have
been shown to act as stabilizing crosslinkers between acidic residues 85–89. Specifically, calcium
ions have been shown to be allosteric effectors that are tightly controlled in eukaryotic cells, as
seen by calmodulin proteins 90–93. Furthermore, aberrant concentrations of metal cations in vivo
have been implicated as possible causes for some neurological diseases due to protein
aggregation or unusually fast folding 58–61. Similarly, polyamines, such as spermine, play
important roles in translation initiation, cell growth, and protein and nucleic acid synthesis 98–101,
yet they have also been identified as a cause for protein misfolding and aggregation 102–105.
Due to their universal influence on stability, folding rates, and most recently discovered
binding rates 106, many have sought to design proteins that are sensitive to multivalent cations
107–113

. Calcium ion binding sites modeled after EF-hands have been introduced into natural

proteins to stabilize the native fold 114–116 and de novo alpha-helix bundles have been designed to
bind Zn2+ ions 117–119.
In addition to multivalent metal sensitivity, allostery has been of high interest to synthetic
biologists as a method for modulating control networks. Allostery is typical in many systems and
present in a large portion of IDPs. The ability to impart and modulate allosteric behavior gives an
attractive additional handle for tuning the properties of our IDPs.
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4.2 Materials and Methods
4.2.1 Protein Preparation. N4(-28) was expressed and purified as previously described
in section 2.3.1.
4.2.2 Salt Refolding. CD spectra were recorded on an Aviv Biomedical Circular
Dichroism Spectrometer Model 400 in a quartz cell with a 0.2 cm light path, using a bandwidth
of 1 – 2 nm, an averaging time of 2 s, and averaged over two scans.
For salt refolding experiments, concentrated apoprotein stocks were prepared at 30 μM in
20 mM MOPS, 15 mM NaCl, pH 7.0. The protein stocks were diluted to 2.5 μM for experiment
samples. Concentrated stocks of titrants were prepared at 20 mM MOPS, 15 mM NaCl, pH 7.0
with the following titrant concentrations: 500 mM CaCl2, 750 mM MgCl2, 10 mM ZnCl2, 10 mM
spermine hydrochloride, and 2 mM TbCl3. Titrants were added at 1 µL additions, mixed by
inversion, and allowed to equilibrate for 1 min – no significant change in the CD spectra was
observed for longer equilibration times. Spectra were recorded between 204 nm and 250 nm,
with background correction. Analysis and folding energy determination are described in section
2.3.2.
4.2.3 Chemical Denaturation. Apo-N4(-28) stocks were prepared at 30 μM in 20 mM
MOPS, pH 7.0 and at four CaCl2 concentrations (24.45, 52.25, 96.15, 186.15 mM). The stocks
were diluted to 2.5 μM in a range of urea concentrations from 0 to 8 M. CD spectra showed no
significant change when the samples were equilibrated for 24 h, therefore equilibration time was
not strictly monitored and was normally on the order of minutes. Spectra were recorded between
210 nm and 250 nm, with background correction. Analysis and folding energy determination are
described in section 2.3.3.
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4.2.4 Cofactor Binding. UV-Vis Spectroscopy — Optical spectra were recorded with a
Hewlett-Packard 8452A diode array spectrophotometer. Apoprotein samples were 0.5 μM in 20
mM MOPS, 50 mM NaCl, pH 7.0 with varying divalent cation concentrations specifically noted
throughout. Experiments were performed in 1 cm path length glass cuvettes. The cofactor,
Fe(III) Isohematoporphyrin IX (IHP) (Frontier Scientific), was suspended in DMSO at
concentrations between 1 mg/mL and 5 mg/mL. Successive 0.3 – 5 equivalent additions of IHP
were followed by at least a 1.5 min equilibration period. Optical spectra were collected after each
equilibration period and the cofactor binding was monitored using the bound IHP Soret peak at
404 nm. Data was normalized to reflect the fraction of protein bound to the cofactor. Values for
K d were obtained from plots of the Soret band absorbance measured at 404 nm vs. the
concentration of IHP added and fit with least squares regression analysis using Equation 6.
4.2.5 Stopped-Flow Analysis of IHP Binding. The kinetics of binding IHP to N4(-28)
were followed spectroscopically in rapid stopped-flow mixing experiments over CaCl2
concentrations from 2 to 80 mM at 25° C using a Biologic SFM 300 stopped-flow mixer
equipped with a custom-built Olis RSM 1000 spectrometer for multiwavelength detection. 20
mM MOPS, 15 mM NaCl, 20 or 80 mM CaCl2 was mixed with buffer not containing CaCl2 in
the first mix, and then this mixture was combined in a second mix with N4(-28), and finally the
resulting mixture was mixed with IHP. Final protein concentrations were 0.5 µM with 2.5 µM
IHP. Holoprotein was followed spectroscopically by following the bound oxidized IHP Soret
band at 404 nm, 𝐴404 . Binding kinetic data were fit with the equation
obs

𝐴404 = (𝐴f − 𝐴0 )𝑒 −𝑡∙𝑘on + 𝐴0 .
Here, 𝐴f is the final absorbance at 404 nm, 𝐴0 is the initial absorbance at 404 nm, 𝑡 is time in
obs
seconds, and 𝑘on
is the effective binding rate constant.
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(10)

4.3 Multivalent Cation Dependence of Folding Energy
Due to the low solubility of many multivalent ions at high pH, the folding energy
dependence of N4(-28) on these ions was determined at pH 7.0. In 20 mM MOPS, 15 mM NaCl,
pH 7.0 buffer apo-N4(-28) has a CD spectrum indicative of a predominantly random coil
structure, yet the development of alpha-helices is extremely sensitive to divalent metals and
spermine hydrochloride (Figure 28). The 95% folded threshold for MgCl2 is just 21 mM, while
for the most sensitive response divalent ions is for ZnCl2 with a 95% folded threshold at 180 µM.
For completeness: the 95% folded threshold is 10 mM for CaCl2 and 250 µM for spermine.
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Figure 28: Circular dichrosim spectra of N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0 titrated with A. MgCl2, B. CaCl2, C.
Spermine, and D. ZnCl2. Inserts show the molar residue ellipticity at 222 nm as a function of titrant concentration.

47

Figure 29A shows the folding energy as a function of cation concentration as determined
from the CD titrations. For all divalent titrants, the folding energy is linearly dependent on the
concentration just as with NaCl with a much higher sensitivity. This indicates that divalent
cations produce stronger screening effects between neighboring glutamate residues than the
monovalent salt NaCl. According to Debye-Hückel theory 120, the amount of screening can be
quantified as a function of the solution ionic strength:
𝜖 𝜖 𝑘 𝑇

0 𝑟 𝑏
𝜆𝐷 = √ 2𝑁
,
𝑒2 𝐼
𝐴

(11)

where 𝜆𝐷 is the Debye length which describes the distance that the electrostatic effect of a charge
persists in an electrolyte solution of ionic strength 𝐼. Further, 𝜖0 is the permittivity of free space,
𝜖𝑟 is the dielectric constant of the solvent, 𝑘𝐵 is Boltzmann’s constant, 𝑇 is the temperature in
Kelvin, 𝑁𝐴 is the Avogadro number, and 𝑒 is the unit charge. For water at room temperature, this
equation simplifies to
𝜆𝐷 =

3.04 Å
√𝐼

.

(12)

Figure 29B shows the folding energy of N4(-28) as a function of Debye length for all cations.
This demonstrates that the higher valancy cations lower the folding energy of the protein at
lower concentrations due to their higher ionic strength, 𝐼, and consequently stronger screening.
Furthermore, it is clear that though a higher valency number of the ions in solution is better for
stabilizing the protein, the valency number alone does not determine the magnitude of this
stabilization. This is evident by the fact that the 95% folded threshold is two orders of magnitude
lower for Zn2+ than Mg2+.
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Figure 29: The folding energy of N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0 as a function (A) divalent titrant
concentration (B) Debye length.

With the clear dependency of N4(-28) folding energy on the valency of the cation in
solution, the trivalent metal, Tb+3, was used as a titrant to determine if a higher valency would
stabilize the protein even further (Figure 30). Similar to previously described salt titrations, N4(28) becomes more alpha-helical as the TbCl3 is added up to a concentration of approximately 30
mM. Interestingly, past 30 mM N4(-28) begins to lose its alpha-helical character and denature.
This is contrary to what is observed with mono- and divalent salts where the addition of more
cations past where the protein is fully folded has no effect on the alpha-helical content.
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Figure 30: A. Circular dichroism spectra of apo-N4(-28) as measured by circular dichroism spectroscopy at increasing NaCl
concentrations. B. The ellipticity value at 222 nm plotted as a function of NaCl concentration. Protein was prepared at a
concentration of 2.5 µM in 20 mM MOPS, pH 7.0 and varying NaCl concentrations.

In section 2.4 it was found that the stability of N4(-28) continues to increase at a constant
rate well past the NaCl concentration at which the protein contains all of its alpha-helical
character. To determine if N4(-28) shows the same behavior with divalent cations, urea
denaturation experiments were conducted at higher CaCl2 concentrations (Figure 31). The
folding energies, 𝛥𝐺fold , from the fits to Equation 5 are summarized in Table 5.
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Figure 31: Urea melts of N4(-28) at pH 7.0, 20 mM MOPS with varying CaCl 2. The fits were calculated using the non-linear
method of least squares to Equation 5.

[CaCl2] (mM)
24.45
52.25
96.15
186.15

𝛥𝐺fold (kcal/mol)
-2.74 ± 0.09
-3.0 ± 0.2
-3.5 ± 0.3
-4.6 ± 0.6

Table 5: The folding energy of N4(-28) at CaCl2 concentrations ranging from 24.45 to 186.15 mM as determined by urea melt
and least squares fit to Equation 5. Errors are determined using the inverse matrix method.

Together, the salt titration and urea melt data demonstrate that, like NaCl, CaCl2
continues to stabilize N4(-28) beyond the point at which it has already completely folded (Figure
32). However, unlike NaCl, there are two distinct regions where the folding energy depends
linearly on the CaCl2 concentration, but with different slopes. Below 10 mM CaCl2, the slope is 0.34 kcal/mol per mM CaCl2, whereas above 10 mM the slope is reduced to -0.01 kcal/mol per
mM CaCl2. This indicates that there are significantly different processes happening in these two
CaCl2 ranges. Notably, when plotted as a function of ionic strength (Figure 33), above an ionic
strength of 0.045 M, the slopes of the folding energy obtained with both CaCl2 and NaCl are the
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same within experimental error. This indicates that with CaCl2, the process happening at higher
ionic strengths is identical to that of NaCl, namely electrostatic screening. At low ionic strengths,
the steeper slope of the folding energy with CaCl2 is suggestive of binding events occurring.

Figure 32: Stability of apo-N4(-28) as a function of CaCl2 concentration as measured by salt titration and urea melt. The best fit
line for each method is drawn.

Figure 33: Stability of apo-N4(-28) as a function of ionic strength for both NaCl and CaCl 2.
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4.4 Cooperative Ligand Binding Triggered by Multivalent Cations
The high density of negative residues on the surface of N4(-28) is favorable for lowering
the folding energy substantially by binding to divalent cations. At 20 mM MOPS, 50 mM NaCl,
pH 7.0, the protein is predominantly unfolded (Figure 34). Adding a small amount of divalent
cation folds N4(-28) only slightly further, yet the protein remains significantly more unfolded
than folded. At 50 mM NaCl, two equivalents of IHP bind weakly with a dissociation constant of
8 ± 1 µM. The addition of 1 mM CaCl2 reduces the dissociation constant to 0.22 ± 0.02 µM,
making the IHP binding significantly tighter. The binding curves for N4(-28) at 50 mM NaCl
and the additional divalent cation are shown in Figure 35. The binding constants, and apparent
binding energies for all divalent cations are shown in Table 6. The large drop in binding energy
for all multivalent cations tested indicates that it is likely Mg2+ and spermine also bind to the
negatively charged surface residues of N4(-28) and drive the dissociation constant down. ZnCl2
does not appear in Table 6 because it precludes the IHP from binding. Zinc is known to form
complexes with bis-His binding sites 121,122, the same that are found in N4(-28), thus the IHP is
unable to enter the binding pocket once the zinc has been added.
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Figure 34: CD spectra of N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0 and with an additional small amount of various
divalent cation.

Figure 35: Binding curves of N4(-28) with IHP. Replot of the IHP Soret band at 404 nm throughout the titration. Data is fit to
Equation 6. Samples were prepared in 20 mM MOPS, 50 mM NaCl, pH 7.0, and an additional amount of divalent cation salt as
specified.
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𝐾𝑑 (µM)

Ion concentrations
50 mM NaCl
50 mM NaCl, 1.5 mM MgCl2
50 mM NaCl, 1 mM CaCl2
50 mM NaCl, 60 µM spermine

8±1
0.52 ± 0.03
0.22 ± 0.02
0.27 ± 0.03

app

𝛥𝐺bind (kcal/mol)
-7.04 ± 0.08
-8.68 ± 0.03
-9.20 ± 0.05
-9.1 ± 0.1

𝐚𝐩𝐩

Table 6: The dissociation constant, 𝑲𝒅 , and apparent binding energy, 𝜟𝑮𝐛𝐢𝐧𝐝 , of N4(-28) with IHP in the presence of
cooperativity inducing divalent cations. Dissociation constants are determined using least squares fits of binding curves to
Equation 6 and errors are determined using the inverse matrix method.

The process by which N4(-28) binds to divalent cations in order to increase its affinity for
a ligand, namely IHP, renders the cations allosteric modulators. This provides another handle for
tuning the folding and binding energy of a supercharged protein. Designing allostery has large
implications in synthetic biology and biosensing for developing molecular switches sensitive to
small fluctuations in ion concentration.

4.5 Rates of IHP Binding
The observed IHP on rates for increasing CaCl2 concentrations are shown in Figure 36A.
At 2 mM CaCl2 the observed on rate is 0.23 ± 0.01 s-1. The fastest rate observed is at 40 mM
CaCl2 with 1.82 ± 0.03 s-1. Although data is shown to CaCl2 concentrations out to 80 mM, the
observed on rates of IHP are effectively constant beyond 40 mM CaCl2 within experimental
obs
error. The data demonstrates that the observed on rate, 𝑘on
, increases with calcium

concentration, indicating that as more of the protein ensemble folds, the available fully formed
binding sites increases allowing for the IHP to bind more readily. Notably, this is the opposite
trend than that of the supercharged extant protein, b562(-18) showed (Figure 27). It follows that
the fraction of N4(-28) that is folded determines the observed IHP on rate. Consequently, the
ratio of the effective on rate to the concentration of molten globule protein, i.e. folded
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apoprotein, is independent of the CaCl2 concentration (Figure 36B), yielding an IHP on rate with
N4(-28) of 1.02 ± 0.02.

Figure 36: A. The effective binding constants of IHP with N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0, in the range of CaCl 2
concentrations from 2 mM to 80 mM. B. The on rate of IHP to N4(-28). Data collected and analyzed by Dr. Mia Brown, to whom
I am eternally grateful for learning to use a stopped-flow on my behalf.
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5. Future Directons: Biosensing

5.1 Applications of Imparting IDP Behavior
The applications of the engineering principles developed to impart IDP behavior to both
designed and natural proteins are far reaching. For example, kinase proteins, which have been
identified as principal players in cancer and other diseases 123, have the key function of
transferring phosphate groups, i.e. negative charge, to other proteins. I am developing a
positively supercharged green fluorescent protein whose chromophore will not mature until the
net charge is reduced by the addition of negative charge by kinases allowing it to fold.
Monitoring kinase activity in vivo could shed light on the roles they play in certain diseases.
Another example of the applications of imparting IDP behavior to natural proteins is
controlling the expression of an indicator protein by making a cation sensitive lac repressor.
Many vector plasmids use the lac operon as a means of controlling the expression of a gene
downstream of it; the lac repressor binds to the DNA at the lac operon preventing gene
expression until lactose or some other binding partner of the repressor is present. By
supercharging the lac repressor so that it is sensitive to small concentrations of divalent cations, I
can monitor the flux of these cations in vivo by the unfolding or folding of the lac repressor and
its subsequent binding to the operon, thereby turning on and off the gene it controls. This can
prove important for identifying and understanding the pathways that are disrupted or activated by
small ion fluxes, such as Ca2+ or Zn 2+ which have been shown to play a part in cell development
124

, neurological signaling 125, phosphatase activity 126, and apoptosis 124,127.
One last example, for which I have developed extensively, lies in using IDPs as

biosensors. The most widely used of the available biosensing techniques relies on
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immunoassays, which often achieve detection sensitivity as low as the ppb range. These assays
use antibodies that bind to the target and produce a signal via a labeling agent, often enzymatic,
radioactive, or fluorescent. In place of label-based techniques, surface plasmon resonance (SPR)
spectroscopy has gained popularity due to its label-free technology 128.

5.2 Supercharged Protein Potential as a Biosensor Using Localized SPR
Localized SPR is a more sensitive version of SPR which uses conductive nanoparticles as
the source of plasmons rather than bulk material. Briefly, when visible light is incident on these
nanoparticles, the incoming electromagnetic field excites plasmons at the surface of the
conductive material. When the wavelength of light matches the plasmon resonance frequency,
the light is absorbed. The resonance frequency is dependent on nanoparticle composition, but
more importantly on the refractive index of the medium near the surface of the nanoparticle
129,130

. Since proteins, such as antibodies, have refractive indexes they can be attached to the

nanoparticles and used to detect their binding partners. When the binding event occurs, the
additional polarizable mass causes a change in the refractive index at the surface of the
nanoparticle and can be sensed by a shift of the peak wavelength of the absorption spectrum. To
date, structurally rigid proteins have been used in SPR, and upon ligand binding there is a
detectable change in refractive index in the range of 0.0001 – 0.001. By using supercharged IDPs
that would undergo a large-scale structural transition upon binding, I could increase the
refractive index change, creating a much more sensitive method for bioassays.
5.2.1 Predicting LSPR Signal. The presence of supercharged IDPs on a gold
nanoparticle will induce a refractive index at the gold/sample interface. After binding to the
target ligand, the protein will undergo a large conformational change that will affect the
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refractive index of the sample just above the gold surface. To determine the magnitude of this
change I will need to estimate the refractive index of our protein using a method outlined by
McMeekin et al. 131,132. The refraction per gram of protein, 𝑅𝑝 , is calculated as the mass weighted
average of the refraction per gram of the contributing amino acids 𝑅𝑎 ,
𝑅𝑝 =

∑𝑎 𝑅𝑎 𝑀𝑎
∑𝑎 𝑀𝑎

,

(13)

where 𝑀𝑎 is the molecular mass of residue 𝑎. Additionally, the partial specific volume of the
protein, 𝜈𝑝 , is calculated as the mass weighted partial specific volume, 𝜈𝑎 , of the contributing
amino acids,
𝜈𝑝 =

∑𝑎 𝑣𝑎 𝑀𝑎
∑𝑎 𝑀𝑎

.

(14)

Finally, by applying the Lorentz-Lorenz formula, an estimate of the refractive index of the
protein is
𝑛=√

2𝑅𝑝 +𝜈𝑝
𝜈𝑝 −𝑅𝑝

.

Using the molar refraction of each amino acid reported by McMeekin

(15)
131

, and the corresponding

partial specific volume reported by Cohn 133, the typical refractive index for our IDP is 𝑛𝑝𝑟𝑜𝑡 =
1.514.
Due to the electrostatic repulsive forces discussed earlier, the protein can be assumed to
have a rigid rod conformation when attached to the gold (Figure 37A). We estimate the volume
of the extended protein as a rectangular box with a square footprint of side length 0.75 nm and a
height of 472.5 nm, i.e. 0.35 nm per amino acid. For simplicity, we will assume each structure
sits on a grid, each occupying one corner of a 2.5 × 2.5 nm square (Figure 37B). The interstitial
space will be filled with water. A simple estimate of the total effective refractive index above the
gold, 𝑛𝑒𝑓𝑓,1 , has been established by Jung et al. 134. The SPR signal is the result of the interaction
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of the evanescent field with the refractive index of the sample. For gold nanoparticles of 100 nm
diameter, the penetration depth of this field is 𝛿 ≈ 40 nm 135 and the intensity decays as 𝑒 −2𝑦/𝛿 .
As such, the effective refractive index is determined by weighting the local refractive index by
the intensity along the perpendicular distance from the gold surface. For our example, the first
472.5 nm have the volume weighted refractive index of the water and protein, and farther out
has the refractive index of water alone,
2

472.5

𝑛𝑒𝑓𝑓,1 = 𝛿 {∫0

∞

(0.0625𝑛𝑝𝑟𝑜𝑡 + 0.9375𝑛𝑤 )𝑒 −2𝑦/𝛿 𝑑𝑦 + ∫472.5 𝑛𝑤 𝑒 −2𝑦/𝛿 } = 1.3415. (16)

Here, 𝑛𝑤 = 1.33, the refractive index of water.
Once the target analyte is introduced the protein will fold into a rigid structure at the
surface of the gold, occupying the entire area of the 2.25 × 2.25 nm square with a height of
5 nm (Figure 3C). Similarly, the effective refractive index can be calculated,
2

5

∞

𝑛𝑒𝑓𝑓,2 = 𝛿 {∫0 𝑛𝑝𝑟𝑜𝑡 𝑒 −2𝑦/𝛿 𝑑𝑦 + ∫5 𝑛𝑤 𝑒 −2𝑦/𝛿 𝑑𝑦} = 1.3707 .

(17)

The predicted shift in the wavelength, 𝛥𝜆, can be determined using the equation
𝛥𝜆 = 𝑚(𝑛𝑒𝑓𝑓,2 − 𝑛𝑒𝑓𝑓,1 ) .

(18)

Here, 𝑚 is the refractive index sensitivity (RIS) in nm/RIU (refractive index unit). The RIS was
experimentally determined to be 130.16 nm/RIS, making the expected shift in resonance
wavelength 3.80 nm. This substantial increase in the effective refractive index upon ligand
binding will result in a resonance wavelength shift almost 30 times the typical SPR signal
obtained for antibody/antigen interaction studies.
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Figure 37: A. Extended supercharged protein conformation attached to gold. B. Top view of protein array where shaded areas
indicate surface area occupied by a single extended protein. Large boxes represent the surface area occupied by a folded protein.
C. Folded protein upon binding to ligand.

This calculation did not account for the charged residues on the IDP and should be
considered a lower limit to the effect of the conformational change on the refractive index. The
carboxylate groups of the charged protein will contribute significantly to the polarizability of the
structure, increasing the effective refractive index above the gold nanoparticles. Also, the RIS
can be tuned and optimized by adjusting the diameter and thickness of the gold nanoparticles 135.
Additionally, strong image charges will be induced on the gold film and may act as a strong
perturbance to the resonance frequency of surface plasmons.

5.3 Materials and Methods
5.3.1 Protein Modification for Au Linkage and Preparation. Genes for the diheme
binding tetrahelical bundles, N4-Cys and N4(-28)-Cys, were were synthesized (GeneWiz) and
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subcloned into the vector plasmid pET32a (Novagen). N4-Cys and N4(-28)-Cys are identical to
their progenitors, N4 and N4(-28), but with a C-terminal cysteine tag consisting of three glycine
residues followed by a cysteine (Table 7). The reactive thiol group at the C-terminus assists in
linking the proteins to the gold. The proteins were expressed and purified as previously described
in section 2.3.1.

Protein
N4-Cys

N4(-28)-Cys

Sequence
GEIWKQHEEALKKFEEALKQFEELKKL
EIWKQHEEALKKFEEALKQFEELKKL
EIWKQHEEALKKFEEALKQFEELKKL
EIWKQHEEALKKFEEALKQFEELKKL
GEIWQQHEEALQQFEEALQQFEELQQL
EIWQQHEEALQQFEEALQQFEELQQL
EIWQQHEEALQQFEEALQQFEELQQL
EIWQQHEEALQQFEEALQQFEELQQL

GGSNSGSGG
GGSSTGSGG
GGSSGGSGG
GGGC
GGSNSGSG
GGGGSSTGSG
GGSSGGSG
GGGC

Table 7: Amino acid sequences for N4-Cys and N4(-28)-Cys, with a C-terminal cysteine for attachment to gold nanoparticles.

5.3.2 Functionalizing Gold Nanoparticles. Self-Assembled Monolayer — Bare gold
nanoparticles attached to glass chips were supplied by Nicoya Lifesciences. The chips were first
cleaned by submersion in piranha solution, followed by thorough washing with water, then
ethanol and dried with N2. Next, the chips were immersed overnight in a 100 mM 3-mercato-1propanol, 1 mM 1-mercaptopropionic acid ethanolic solution to form a self-assembled
monolayer (SAM). Afterwards, the chips were washed with ethanol, dried with N2, and placed in
the SPR spectrometer (Nicoya Lifesciences). Prior to surface attachment, the lyophilized protein
was resuspended in Protein Coupling Buffer (20 mM HEPES, pH 7.0, 750 mM NaCl), degassed,
reduced with 10x molar excess of TCEP (Tris(2-carboxyethyl)phosphine hydrochloride), and
allowed to sit at room temperature under nitrogen for approximately 30 min.
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Linking Protein to SAM via a Bifunctional Crosslinker — The gold nanoparticle covered
surface with the SAM was equilibrated with 10 mM MES pH 5.5. To begin, the surface was
exposed to 200 mM EDC (N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride) and
2 mM MPA (3-maleimido-propionic acid) for 8 min, during which an intermediate was formed
by the two free molecules which then covalently bound to the SAM at the amine group (reaction
1 and 2 in Figure 38). This step was followed by quickly washing with degassed Protein
Coupling Buffer (20 mM HEPES pH 7.0, 750 mM NaCl ). Next, the reduced and degassed
protein was allowed to flow over the chip for 20 min (reaction 3 in Figure 38), followed by a
wash with Protein Coupling Buffer. Finally, the unreacted maleimide terminated molecules were
blocked and inactivated by flowing 1 M 2-mercaptoethanol over the fully functionalized chip for
7 min, followed by washing with 50 mM HCl to recharge.

Figure 38: Reaction scheme for attachment of protein to amine-terminated SAM on Au nanoparticles.

5.3.3 SPR Spectroscopy. The functionalized chip was equilibrated with Experiment
Buffer (20 mM HEPES, 15 mM NaCl, pH 7.0) at a flow rate of 50 µL/min. Then 80 µL of 2 mM
ZnCl2 in Experiment Buffer, was injected into the SPR line and flowed over the chip and the
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change in SPR signal was observed. Finally, the chip would be washed with Experiment Buffer
to recharge the surface.

5.4 SPR Response to Protein Folding
In early studies I found that heme and IHP tended to lodge itself in the monolayer due to
its hydrophobic character, causing an irreversible shift in the SPR signal, and was therefore not a
reliable indicator of whether a conformational change had occurred. From section 4.3, divalent
salts are capable of driving the conformational change at concentrations up to three orders of
magnitude lower than monovalent salts. N4(-28)-Cys undergoes a conformational change with
the addition of 2 mM ZnCl2, while an equivalent amount of ZnCl2 has no effect on the
conformation of the neutral N4-Cys. Therefore, 2 mM ZnCl2 was used instead of heme or IHP to
induce a conformational change in gold-bound N4(-28)-Cys.
The SPR responses of chip functionalization and protein folding for both N4-Cys and
N4(-28)-Cys are shown in Figure 39. Since the refractive indices of N4-Cys and N4(-28)-Cys
should be approximately identical according to the calculations in section 5.1, the SPR response
to the fully folded structures should be the same. Because the protein coupling reaction is
performed at high ionic strength, both structures are folded during this step, and so a larger
change in the SPR signal indicates a high concentration of surface-attached protein. As such, it is
obvious that the 1.09 nm shift in the SPR signal when attaching N4-Cys indicates it attached
two-fold more efficiently than N4(-28)-Cys, which only displayed a 0.52 nm shift.
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Figure 39: Time course display of the SPR response for both A. N4 and B. N4(-28) during functionalization and the ZnCl 2
sensing experiment.

To determine the protein folding response, 2 mM ZnCl2, 20 mM HEPES pH 7, 15 mM
NaCl was injected to flow over the functionalized chip. N4-Cys and N4(-28)-Cys showed a 0.12
nm and 0.22 nm increase in the SPR response, respectively. Correcting for the relative protein
concentrations, we conclude that the SPR shift per protein molecule for N4-Cys is 0.11 nm and
for N4(-28)-Cys is 0.43 nm. Hence with this method, we have shown the conformational change
of N4(-28)-Cys yields a response that is 3.75-fold greater with than with N4-Cys. This signal
enhancement is modest when compared to the theoretical calculations above, but I believe that
the sensitivity can be improved by optimizing the size and shape of the gold nano-features on the
glass slide.
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